These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20333876)

  • 1. Enzyme replacement therapy in an infant with Pompe's disease with severe cardiomyopathy.
    Tanzer F; Buyukkayhan D; Cansu Mutlu E; Kalender Korkmaz F
    J Pediatr Endocrinol Metab; 2009 Dec; 22(12):1159-62. PubMed ID: 20333876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apical Hypertrophic Cardiomyopathy in an Infant: First Presentation of Pompe's Disease.
    Patra S; Subramaniun A; Mahimaiha J; Sastry UM; Nanjappa MC
    World J Pediatr Congenit Heart Surg; 2014 Jul; 5(3):491-3. PubMed ID: 24958062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the enzyme replacement therapy on hypertrophic cardiomyopathy in an infant with the CRIM-negative infantile Pompe's disease.
    Vaksmann G; Guemann AS; Mention K
    Pediatr Neonatol; 2021 May; 62(3):333-334. PubMed ID: 33358862
    [No Abstract]   [Full Text] [Related]  

  • 4. [Enzyme replacement therapy in Pompe's disease].
    Merk T; Wibmer T; Schumann C; Krüger S
    Med Klin (Munich); 2007 Jul; 102(7):570-3. PubMed ID: 17634875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy.
    Winkel LP; Kamphoven JH; van den Hout HJ; Severijnen LA; van Doorn PA; Reuser AJ; van der Ploeg AT
    Muscle Nerve; 2003 Jun; 27(6):743-51. PubMed ID: 12766987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report of the first Brazilian infantile Pompe disease patient to be treated with recombinant human acid alpha-glucosidase.
    Pereira SJ; Berditchevisky CR; Marie SK
    J Pediatr (Rio J); 2008; 84(3):272-5. PubMed ID: 18535739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human alpha-glucosidase from rabbit milk in Pompe patients.
    Van den Hout H; Reuser AJ; Vulto AG; Loonen MC; Cromme-Dijkhuis A; Van der Ploeg AT
    Lancet; 2000 Jul; 356(9227):397-8. PubMed ID: 10972374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-onset Pompe's disease.
    Teener JW
    Semin Neurol; 2012 Nov; 32(5):506-11. PubMed ID: 23677658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical manifestations, course and outcome of enzyme replacement therapy in Hungarian patients with Pompe's disease].
    Bereznai B; Trauninger A; György I; Szakszon K; Almássy Z; Pál E; Herczegfalvi A; Várdi Visy K; Illés Z; Molnár MJ
    Orv Hetil; 2011 Sep; 152(39):1569-75. PubMed ID: 21920843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unusual presentation of metabolic cardiomyopathy due to Pompe's disease.
    Venugopalan P; Ahmed S; Rao VT; Al-Hinai KM
    Saudi Med J; 2002 Mar; 23(3):338-40. PubMed ID: 11938430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Three hypotonic neonates with hypertrophic cardiomyopathy: Pompe's disease].
    Willemsen MA; Jira PE; Gabreëls FJ; van der Ploeg AT; Smeitink JA
    Ned Tijdschr Geneeskd; 1998 Jun; 142(24):1388-92. PubMed ID: 9752027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac remodeling after enzyme replacement therapy with acid alpha-glucosidase for infants with Pompe disease.
    Levine JC; Kishnani PS; Chen YT; Herlong JR; Li JS
    Pediatr Cardiol; 2008 Nov; 29(6):1033-42. PubMed ID: 18661169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An interesting case of infant sudden death: severe hypertrophic cardiomyopathy in Pompe's disease.
    Metzl JD; Elias ER; Berul CI
    Pacing Clin Electrophysiol; 1999 May; 22(5):821-2. PubMed ID: 10353146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pompe's disease. Part I: pathogenesis and clinical features].
    Illés Z; Trauninger A
    Ideggyogy Sz; 2009 Jul; 62(7-8):231-43. PubMed ID: 19685701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pompe's disease: the role for early diagnosis and treatment].
    Cerini E; Bini M; Donati A; Andaloro L; Compagnoni G
    Pediatr Med Chir; 2007; 29(5):270-2. PubMed ID: 18402397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up.
    Winkel LP; Van den Hout JM; Kamphoven JH; Disseldorp JA; Remmerswaal M; Arts WF; Loonen MC; Vulto AG; Van Doorn PA; De Jong G; Hop W; Smit GP; Shapira SK; Boer MA; van Diggelen OP; Reuser AJ; Van der Ploeg AT
    Ann Neurol; 2004 Apr; 55(4):495-502. PubMed ID: 15048888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pompe's disease.
    van der Ploeg AT; Reuser AJ
    Lancet; 2008 Oct; 372(9646):1342-53. PubMed ID: 18929906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A retrospective study of six patients with late-onset Pompe disease].
    Saux A; Laforet P; Pagès AM; Figarella-Branger D; Pellissier JF; Pagès M; Labauge P
    Rev Neurol (Paris); 2008 Apr; 164(4):336-42. PubMed ID: 18439925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two cases of Pompe's disease: case report and review of literature.
    Jegadeeswari A; Amuthan V; Janarthanan RA; Murugan S; Balasubramanian S
    Indian Heart J; 2012; 64(2):214-6. PubMed ID: 22572506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature.
    van den Hout HM; Hop W; van Diggelen OP; Smeitink JA; Smit GP; Poll-The BT; Bakker HD; Loonen MC; de Klerk JB; Reuser AJ; van der Ploeg AT
    Pediatrics; 2003 Aug; 112(2):332-40. PubMed ID: 12897283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.